First Time Loading...

BG Medicine Inc
OTC:BGMD

Watchlist Manager
BG Medicine Inc Logo
BG Medicine Inc
OTC:BGMD
Watchlist
Price: 0.0001 USD Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

BGMD Price Targets Summary
BG Medicine Inc

There are no price targets for BGMD.
BGMD Lowest Forecast
Wall Street Target
Not Available
BGMD Average Forecast
Wall Street Target
Not Available
BGMD Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
BG Medicine Inc Competitors:
Price Targets
DHR
Danaher Corp
11% Upside
F
FTRE
Fortrea Holdings Inc
10% Upside
CSBR
Champions Oncology Inc
19% Upside
4YL
Nanoform Finland Oyj
88% Upside
DHR
Danaher Corp
11% Upside
F
FTRE
Fortrea Holdings Inc
10% Upside
CSBR
Champions Oncology Inc
19% Upside
4YL
Nanoform Finland Oyj
88% Upside
ILMN
Illumina Inc
32% Upside
B
086040
Biotoxtech Co Ltd
161% Upside
GXI
Gerresheimer AG
31% Upside
ERF
Eurofins Scientific SE
9% Upside

Revenue
Forecast

Revenue Estimate
BG Medicine Inc

For the last 5 years the compound annual growth rate for BG Medicine Inc's revenue is 14%. The projected CAGR for the next 1 year is 95%.

14%
Past Growth
95%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
BG Medicine Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
BG Medicine Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-54%
Average Miss
What are analyst estimates?

See Also

Summary
BGMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
BGMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BGMD stock valuation using valuation multiples.
Wall Street Estimates
BGMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BGMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BGMD's stock price target?
Not Available

BGMD doesn't have any price targets made by Wall Street professionals.

What is BG Medicine Inc's Revenue forecast?
Projected CAGR
95%

For the last 5 years the compound annual growth rate for BG Medicine Inc's revenue is 14%. The projected CAGR for the next 1 year is 95%.

ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.